Literature DB >> 22706087

Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity.

Sheinei J Saleem1, Rebecca K Martin, Johanna K Morales, Jamie L Sturgill, David R Gibb, Laura Graham, Harry D Bear, Masoud H Manjili, John J Ryan, Daniel H Conrad.   

Abstract

Myeloid-derived suppressor cells (MDSCs) are primarily recognized for their immunosuppressive properties in malignant disease. However, their interaction with other innate immune cells and their regulation of immune responses, such as in parasitic infection, necessitate further characterization. We used our previously published mouse model of MDSC accumulation to examine the immunoregulatory role of MDSCs in B16 melanoma metastasis and Nippostrongylus brasiliensis infection. In this study, we demonstrate that the activity of MDSCs is dependent on the immune stimuli and subset induced. Monocytic MDSCs predictably suppressed antitumor immune responses but granulocytic MDSCs surprisingly enhanced the clearance of N. brasiliensis infection. Intriguingly, both results were dependent on MDSC interaction with mast cells (MCs), as demonstrated by adoptive-transfer studies in MC-deficient (Kit(Wsh)(/)(Wsh)) mice. These findings were further supported by ex vivo cocultures of MCs and MDSCs, indicating a synergistic increase in cytokine production. Thus, MCs can enhance both immunosuppressive and immunosupportive functions of MDSCs.

Entities:  

Mesh:

Year:  2012        PMID: 22706087      PMCID: PMC3392490          DOI: 10.4049/jimmunol.1200647

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.

Authors:  V Bronte; E Apolloni; A Cabrelle; R Ronca; P Serafini; P Zamboni; N P Restifo; P Zanovello
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

2.  Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.

Authors:  Laura Bracci; Federica Moschella; Paola Sestili; Valentina La Sorsa; Mara Valentini; Irene Canini; Sara Baccarini; Sonia Maccari; Carlo Ramoni; Filippo Belardelli; Enrico Proietti
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 3.  Animal model of Nippostrongylus brasiliensis and Heligmosomoides polygyrus.

Authors:  Mali Camberis; Graham Le Gros; Joseph Urban
Journal:  Curr Protoc Immunol       Date:  2003-08

4.  IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.

Authors:  Heth R Turnquist; Zhenlin Zhao; Brian R Rosborough; Quan Liu; Antonino Castellaneta; Kumiko Isse; Zhiliang Wang; Megan Lang; Donna Beer Stolz; Xin Xiao Zheng; A Jake Demetris; Foo Y Liew; Kathryn J Wood; Angus W Thomson
Journal:  J Immunol       Date:  2011-09-26       Impact factor: 5.422

5.  Sensitizing T-lymphocytes for adoptive immunotherapy by vaccination with wild-type or cytokine gene-transduced melanoma.

Authors:  K A Lipshy; P J Kostuchenko; G G Hamad; C E Bland; S K Barrett; H D Bear
Journal:  Ann Surg Oncol       Date:  1997-06       Impact factor: 5.344

Review 6.  Mucosal mast cells and the allergic response against nematode parasites.

Authors:  H R Miller
Journal:  Vet Immunol Immunopathol       Date:  1996-11       Impact factor: 2.046

Review 7.  A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma.

Authors:  Alex G Cuenca; Matthew J Delano; Kindra M Kelly-Scumpia; Claudia Moreno; Philip O Scumpia; Drake M Laface; Paul G Heyworth; Philip A Efron; Lyle L Moldawer
Journal:  Mol Med       Date:  2010-11-12       Impact factor: 6.354

8.  Kinetics of expulsion of the nematode, Nippostrongylus brasiliensis, in mast-cell deficient W/WV mice.

Authors:  L A Mitchell; R B Wescott; L E Perryman
Journal:  Parasite Immunol       Date:  1983-01       Impact factor: 2.280

Review 9.  Intestinal nematode parasites, cytokines and effector mechanisms.

Authors:  K J Else; F D Finkelman
Journal:  Int J Parasitol       Date:  1998-08       Impact factor: 3.981

10.  Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis.

Authors:  J R Starkey; P K Crowle; S Taubenberger
Journal:  Int J Cancer       Date:  1988-07-15       Impact factor: 7.396

View more
  45 in total

1.  Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma.

Authors:  Raffaella Iannone; Lucio Miele; Piera Maiolino; Aldo Pinto; Silvana Morello
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

2.  Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease.

Authors:  Kristen R Crook; Mengyao Jin; Michael F Weeks; Rishi R Rampersad; Robert M Baldi; Amy S Glekas; Yajuan Shen; Denise A Esserman; Paul Little; Todd A Schwartz; Peng Liu
Journal:  J Leukoc Biol       Date:  2015-01-12       Impact factor: 4.962

3.  Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells.

Authors:  Rebecca K Martin; Sheinei J Saleem; Lauren Folgosa; Hannah B Zellner; Sheela R Damle; Giang-Kim T Nguyen; John J Ryan; Harry D Bear; Anne-Marie Irani; Daniel H Conrad
Journal:  J Leukoc Biol       Date:  2014-03-07       Impact factor: 4.962

4.  DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer.

Authors:  Krista P Terracina; Laura J Graham; Kyle K Payne; Masoud H Manjili; Annabel Baek; Sheela R Damle; Harry D Bear
Journal:  Cancer Immunol Immunother       Date:  2016-07-14       Impact factor: 6.968

5.  Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses.

Authors:  Johanna K Morales; Sheinei J Saleem; Rebecca K Martin; Bryan L Saunders; Brian O Barnstein; Travis W Faber; Nicholas A Pullen; Elizabeth Motunrayo Kolawole; Keith B Brooks; Sarah K Norton; Jamie Sturgill; Laura Graham; Harry D Bear; Joseph F Urban; Chris S Lantz; Daniel H Conrad; John J Ryan
Journal:  J Leukoc Biol       Date:  2013-12-12       Impact factor: 4.962

6.  Tolerance and immune suppression in the tumor microenvironment.

Authors:  Suzanne Ostrand-Rosenberg
Journal:  Cell Immunol       Date:  2015-09-30       Impact factor: 4.868

7.  Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor γ in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo.

Authors:  Venkatesh L Hegde; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Immunol       Date:  2015-04-27       Impact factor: 5.422

8.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

Review 9.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

Authors:  Katherine H Parker; Daniel W Beury; Suzanne Ostrand-Rosenberg
Journal:  Adv Cancer Res       Date:  2015-05-12       Impact factor: 6.242

10.  Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.

Authors:  Daniel W Beury; Katherine H Parker; Maeva Nyandjo; Pratima Sinha; Kayla A Carter; Suzanne Ostrand-Rosenberg
Journal:  J Leukoc Biol       Date:  2014-08-28       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.